The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral COVID-19 Vaccine Market Research Report 2024
Synopsis
Global Oral COVID-19 Vaccine market is projected to reach US$ 1211.9 million in 2029, increasing from US$ 842 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral COVID-19 Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral COVID-19 Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
CanSino Biologics
Kindred Biosciences, Inc.
Zhejiang Huahai Pharmaceutical Co.,ltd.
Shandong Xinhua Pharmaceutical
Kintor Pharmaceutical
Henan Genuine Biotech Co., Ltd.
Segment by Type
Tablet Type
Inhalable Type
Segment by Application
Adults
Children
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral COVID-19 Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Oral COVID-19 Vaccine market is projected to reach US$ 1211.9 million in 2029, increasing from US$ 842 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral COVID-19 Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral COVID-19 Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
CanSino Biologics
Kindred Biosciences, Inc.
Zhejiang Huahai Pharmaceutical Co.,ltd.
Shandong Xinhua Pharmaceutical
Kintor Pharmaceutical
Henan Genuine Biotech Co., Ltd.
Segment by Type
Tablet Type
Inhalable Type
Segment by Application
Adults
Children
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral COVID-19 Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral COVID-19 Vaccine Market Overview
1.1 Product Overview and Scope of Oral COVID-19 Vaccine
1.2 Oral COVID-19 Vaccine Segment by Type
1.2.1 Global Oral COVID-19 Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Tablet Type
1.2.3 Inhalable Type
1.3 Oral COVID-19 Vaccine Segment by Application
1.3.1 Global Oral COVID-19 Vaccine Market Value by Application: (2023-2029)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Oral COVID-19 Vaccine Market Size Estimates and Forecasts
1.4.1 Global Oral COVID-19 Vaccine Revenue 2018-2029
1.4.2 Global Oral COVID-19 Vaccine Sales 2018-2029
1.4.3 Global Oral COVID-19 Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral COVID-19 Vaccine Market Competition by Manufacturers
2.1 Global Oral COVID-19 Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral COVID-19 Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral COVID-19 Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Oral COVID-19 Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral COVID-19 Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral COVID-19 Vaccine, Product Type & Application
2.7 Oral COVID-19 Vaccine Market Competitive Situation and Trends
2.7.1 Oral COVID-19 Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral COVID-19 Vaccine Players Market Share by Revenue
2.7.3 Global Oral COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral COVID-19 Vaccine Retrospective Market Scenario by Region
3.1 Global Oral COVID-19 Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral COVID-19 Vaccine Global Oral COVID-19 Vaccine Sales by Region: 2018-2029
3.2.1 Global Oral COVID-19 Vaccine Sales by Region: 2018-2023
3.2.2 Global Oral COVID-19 Vaccine Sales by Region: 2024-2029
3.3 Global Oral COVID-19 Vaccine Global Oral COVID-19 Vaccine Revenue by Region: 2018-2029
3.3.1 Global Oral COVID-19 Vaccine Revenue by Region: 2018-2023
3.3.2 Global Oral COVID-19 Vaccine Revenue by Region: 2024-2029
3.4 North America Oral COVID-19 Vaccine Market Facts & Figures by Country
3.4.1 North America Oral COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral COVID-19 Vaccine Sales by Country (2018-2029)
3.4.3 North America Oral COVID-19 Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral COVID-19 Vaccine Market Facts & Figures by Country
3.5.1 Europe Oral COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral COVID-19 Vaccine Sales by Country (2018-2029)
3.5.3 Europe Oral COVID-19 Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral COVID-19 Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral COVID-19 Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral COVID-19 Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral COVID-19 Vaccine Market Facts & Figures by Country
3.7.1 Latin America Oral COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral COVID-19 Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Oral COVID-19 Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral COVID-19 Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral COVID-19 Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral COVID-19 Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral COVID-19 Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral COVID-19 Vaccine Sales by Type (2018-2029)
4.1.1 Global Oral COVID-19 Vaccine Sales by Type (2018-2023)
4.1.2 Global Oral COVID-19 Vaccine Sales by Type (2024-2029)
4.1.3 Global Oral COVID-19 Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Oral COVID-19 Vaccine Revenue by Type (2018-2029)
4.2.1 Global Oral COVID-19 Vaccine Revenue by Type (2018-2023)
4.2.2 Global Oral COVID-19 Vaccine Revenue by Type (2024-2029)
4.2.3 Global Oral COVID-19 Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Oral COVID-19 Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral COVID-19 Vaccine Sales by Application (2018-2029)
5.1.1 Global Oral COVID-19 Vaccine Sales by Application (2018-2023)
5.1.2 Global Oral COVID-19 Vaccine Sales by Application (2024-2029)
5.1.3 Global Oral COVID-19 Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Oral COVID-19 Vaccine Revenue by Application (2018-2029)
5.2.1 Global Oral COVID-19 Vaccine Revenue by Application (2018-2023)
5.2.2 Global Oral COVID-19 Vaccine Revenue by Application (2024-2029)
5.2.3 Global Oral COVID-19 Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Oral COVID-19 Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Oral COVID-19 Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 CanSino Biologics
6.2.1 CanSino Biologics Corporation Information
6.2.2 CanSino Biologics Description and Business Overview
6.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CanSino Biologics Oral COVID-19 Vaccine Product Portfolio
6.2.5 CanSino Biologics Recent Developments/Updates
6.3 Kindred Biosciences, Inc.
6.3.1 Kindred Biosciences, Inc. Corporation Information
6.3.2 Kindred Biosciences, Inc. Description and Business Overview
6.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio
6.3.5 Kindred Biosciences, Inc. Recent Developments/Updates
6.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
6.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Corporation Information
6.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Description and Business Overview
6.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio
6.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments/Updates
6.5 Shandong Xinhua Pharmaceutical
6.5.1 Shandong Xinhua Pharmaceutical Corporation Information
6.5.2 Shandong Xinhua Pharmaceutical Description and Business Overview
6.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
6.5.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
6.6 Kintor Pharmaceutical
6.6.1 Kintor Pharmaceutical Corporation Information
6.6.2 Kintor Pharmaceutical Description and Business Overview
6.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
6.6.5 Kintor Pharmaceutical Recent Developments/Updates
6.7 Henan Genuine Biotech Co., Ltd.
6.6.1 Henan Genuine Biotech Co., Ltd. Corporation Information
6.6.2 Henan Genuine Biotech Co., Ltd. Description and Business Overview
6.6.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio
6.7.5 Henan Genuine Biotech Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral COVID-19 Vaccine Industry Chain Analysis
7.2 Oral COVID-19 Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral COVID-19 Vaccine Production Mode & Process
7.4 Oral COVID-19 Vaccine Sales and Marketing
7.4.1 Oral COVID-19 Vaccine Sales Channels
7.4.2 Oral COVID-19 Vaccine Distributors
7.5 Oral COVID-19 Vaccine Customers
8 Oral COVID-19 Vaccine Market Dynamics
8.1 Oral COVID-19 Vaccine Industry Trends
8.2 Oral COVID-19 Vaccine Market Drivers
8.3 Oral COVID-19 Vaccine Market Challenges
8.4 Oral COVID-19 Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
